The global Human Milk Oligosaccharides (HMO) Market size is projected to reach a CAGR of 23.4% from 2023-2030.
Human milk oligosaccharides, also known as human milk glycans, are short polymers of simple sugars that can be found in high concentrations exclusively in human breast milk. Human milk oligosaccharides promote the development of the immune system, can reduce pathogen infections, and improve brain development and cognition. Approximately 200 structurally different human milk oligosaccharides are known and the exact composting of these varies from mother to mother.
The functional benefits of these products have created a huge demand for the biosynthetic production of HMOs for use as additives in infant formulas and other dietary products. HMO molecules can be produced chemically, through fermentation, or through enzymatic synthesis. Moreover, the surge in demand for HMOs has increased the utilization of various nutritional products used as food or dietary supplements. One of the major factors and Human Milk Oligosaccharides (HMO) market trends that boosts the Human Milk Oligosaccharides (HMO) market growth is the availability of new technologies such as enzymatic trans-glycosylation, which is used for artificially synthesizing the HMOs. Other major factors driving the demand for HMOs around the world include improvement in lifestyle and rise in concerns about health & wellness. Furthermore, HMOs in food supplements and functional food and beverage products can aid in the treatment of specific disorders and high-risk health conditions, which is acts as a key driving force of the global Human Milk Oligosaccharides (HMO) market. This has created Human Milk Oligosaccharides (HMO) market opportunity. However, high costs associated with the product is expected to pose a challenge for the growth of the market during Human Milk Oligosaccharides (HMO) market forecast.
On the other hand, the absence of technologies for large-scale manufacturing, the massive price of research and development, and the rigorous federal regulations are all expected to limit the expansion of the HMO industry. Additionally, it is possible that the high prices connected with the goods would hinder market expansion throughout the projection period.
The COVID-19 pandemic had a significant impact on the Human Milk Oligosaccharides (HMO) market. The demand for HMO increased during the lockdown due to panic buying for at-home consumption during the initial phase of the pandemic. As a result, the sales of HMOs escalated during the pandemic, due to the fact that it serves as an immunity booster.
The demand for infant formula-containing HMOs and increased awareness of the health advantages of HMOs are driving the growth and dynamism of the human milk oligosaccharides (HMO) market. While there are now many competitors operating in the industry, it is fragmented, and there are some consolidations as larger businesses want to increase their offers and acquire a competitive edge. Regulatory oversight of the market is also present, notably in relation to the efficacy and safety of HMOs used in baby formula. Overall, it is anticipated that the HMO market will expand over the upcoming years as a result of growing demand from emerging nations and ongoing studies into the health advantages of HMOs.
Asia Pacific to Dominate the Market
